- 100% Optical
- Equipment & Machinery
LumiThera® is a medical device company focused on treating patients affected by ocular damage and disease, including dry age-related macular degeneration. LumiThera’s flagship product, the Valeda® Light Delivery System, is the first approved treatment for dry AMD using photobiomodulation in the EU. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease-of-use in the clinician’s office. LumiThera also offers the Diopsys electrophysiology (ERG) device to help clinicians analyze the entire visual pathway for visual and neuro-visual disorders. Visit the LumiThera stand to learn more about this comprehensive solution to diagnose, treat, and monitor patients.
LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Valeda® Light Delivery System Treatments in Dry Age-Related Macular Degeneration Patients